These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23539108)

  • 1. The use and reporting of patient-reported outcomes in phase III breast cancer trials.
    Brim RL; Pearson SD
    Clin Trials; 2013 Apr; 10(2):243-9. PubMed ID: 23539108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology.
    Bariani GM; de Celis Ferrari AC; Hoff PM; Krzyzanowska MK; Riechelmann RP
    J Clin Oncol; 2013 Jun; 31(18):2289-95. PubMed ID: 23630201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
    Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
    Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
    Ataman OU; Sambrook SJ; Wilks C; Lloyd A; Taylor AE; Wedge SR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e447-54. PubMed ID: 22819210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reporting phase I trial results in ClinicalTrials.gov and matched publications.
    Shepshelovich D; Goldvaser H; Wang L; Abdul Razak AR; Bedard PL
    Invest New Drugs; 2017 Dec; 35(6):827-833. PubMed ID: 28905282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of the trial outcome was associated with publication rate and time to publication.
    Song SY; Koo DH; Jung SY; Kang W; Kim EY
    J Clin Epidemiol; 2017 Apr; 84():78-84. PubMed ID: 28238789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations.
    Ruther NR; Mathiason MA; Wee SK; Emmel AE; Go RS
    Am J Clin Oncol; 2015 Dec; 38(6):575-82. PubMed ID: 24517955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Publication status of contemporary oncology randomised controlled trials worldwide.
    Chen YP; Liu X; Lv JW; Li WF; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
    Eur J Cancer; 2016 Oct; 66():17-25. PubMed ID: 27522246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials.
    Perlmutter AS; Tran VT; Dechartres A; Ravaud P
    Ann Oncol; 2017 Apr; 28(4):688-695. PubMed ID: 28011448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
    Stefanovic S; Wallwiener M; Karic U; Domschke C; Katic L; Taran FA; Pesic A; Hartkopf A; Hadji P; Teufel M; Schuetz F; Sohn C; Fasching P; Schneeweiss A; Brucker S
    Support Care Cancer; 2017 Feb; 25(2):549-558. PubMed ID: 27747478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of race and ethnicity in breast cancer research: room for improvement.
    Mitchell KW; Carey LA; Peppercorn J
    Breast Cancer Res Treat; 2009 Dec; 118(3):511-7. PubMed ID: 19444602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and impact of correlative science in breast cancer phase II trials.
    Zhang T; Schneider A; Hamilton EP; Patel K; Kamal AH; Lyman GH; Peppercorn JM
    Breast Cancer Res Treat; 2013 Jun; 139(3):845-50. PubMed ID: 23771715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
    Kahn KL; Schneider EC; Malin JL; Adams JL; Epstein AM
    Med Care; 2007 May; 45(5):431-9. PubMed ID: 17446829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.